Atopic dermatitis trials recruiting in New York

All Atopic dermatitis trials nationally

Cities in New York

Recruiting trials in New York

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
  NCT07277660 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, The Bronx
• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07599813 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
  NCT05995964 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: East Syracuse, New York
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
  NCT06808477 · Phase: Phase 1 · Ages: 18 Years to 72 Years · Sex: All (male and female) · New York: New York, The Bronx
• A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
  NCT05721937 · Phase: Not specified · Ages: 0 Years and older · Sex: Female · New York: New York
• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
  NCT06389136 · Phase: Phase 3 · Ages: 18 Years to 63 Years · Sex: All (male and female) · New York: Kew Gardens, New York
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07037901 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: Kew Gardens, New York, Woodbury
• A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
  NCT07216027 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · New York: The Bronx
• Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
  NCT07746427 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 17 Years · Sex: All (male and female) · New York: New York
• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
  NCT06947993 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · New York: Brooklyn
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
  NCT06988605 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · New York: Auburn, East Syracuse, Mount Kisco, New York
• Skin Microbial Ecology in Atopic Dermatitis
  NCT04170244 · Phase: Not specified · Ages: 13 Years and older · Sex: All (male and female) · New York: Rochester
• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
  NCT06504160 · Phase: Phase 1 · Ages: 6 Years and older · Sex: All (male and female) · New York: New York, Rochester
• Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
  NCT07242638 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · New York: New York